Cargando…

Individual dynamic prediction of clinical endpoint from large dimensional longitudinal biomarker history: a landmark approach

BACKGROUND: The individual data collected throughout patient follow-up constitute crucial information for assessing the risk of a clinical event, and eventually for adapting a therapeutic strategy. Joint models and landmark models have been proposed to compute individual dynamic predictions from rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Devaux, Anthony, Genuer, Robin, Peres, Karine, Proust-Lima, Cécile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275051/
https://www.ncbi.nlm.nih.gov/pubmed/35818025
http://dx.doi.org/10.1186/s12874-022-01660-3
_version_ 1784745413102796800
author Devaux, Anthony
Genuer, Robin
Peres, Karine
Proust-Lima, Cécile
author_facet Devaux, Anthony
Genuer, Robin
Peres, Karine
Proust-Lima, Cécile
author_sort Devaux, Anthony
collection PubMed
description BACKGROUND: The individual data collected throughout patient follow-up constitute crucial information for assessing the risk of a clinical event, and eventually for adapting a therapeutic strategy. Joint models and landmark models have been proposed to compute individual dynamic predictions from repeated measures to one or two markers. However, they hardly extend to the case where the patient history includes much more repeated markers. Our objective was thus to propose a solution for the dynamic prediction of a health event that may exploit repeated measures of a possibly large number of markers. METHODS: We combined a landmark approach extended to endogenous markers history with machine learning methods adapted to survival data. Each marker trajectory is modeled using the information collected up to the landmark time, and summary variables that best capture the individual trajectories are derived. These summaries and additional covariates are then included in different prediction methods adapted to survival data, namely regularized regressions and random survival forests, to predict the event from the landmark time. We also show how predictive tools can be combined into a superlearner. The performances are evaluated by cross-validation using estimators of Brier Score and the area under the Receiver Operating Characteristic curve adapted to censored data. RESULTS: We demonstrate in a simulation study the benefits of machine learning survival methods over standard survival models, especially in the case of numerous and/or nonlinear relationships between the predictors and the event. We then applied the methodology in two prediction contexts: a clinical context with the prediction of death in primary biliary cholangitis, and a public health context with age-specific prediction of death in the general elderly population. CONCLUSIONS: Our methodology, implemented in R, enables the prediction of an event using the entire longitudinal patient history, even when the number of repeated markers is large. Although introduced with mixed models for the repeated markers and methods for a single right censored time-to-event, the technique can be used with any other appropriate modeling technique for the markers and can be easily extended to competing risks setting. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at (10.1186/s12874-022-01660-3).
format Online
Article
Text
id pubmed-9275051
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92750512022-07-13 Individual dynamic prediction of clinical endpoint from large dimensional longitudinal biomarker history: a landmark approach Devaux, Anthony Genuer, Robin Peres, Karine Proust-Lima, Cécile BMC Med Res Methodol Technical Advance BACKGROUND: The individual data collected throughout patient follow-up constitute crucial information for assessing the risk of a clinical event, and eventually for adapting a therapeutic strategy. Joint models and landmark models have been proposed to compute individual dynamic predictions from repeated measures to one or two markers. However, they hardly extend to the case where the patient history includes much more repeated markers. Our objective was thus to propose a solution for the dynamic prediction of a health event that may exploit repeated measures of a possibly large number of markers. METHODS: We combined a landmark approach extended to endogenous markers history with machine learning methods adapted to survival data. Each marker trajectory is modeled using the information collected up to the landmark time, and summary variables that best capture the individual trajectories are derived. These summaries and additional covariates are then included in different prediction methods adapted to survival data, namely regularized regressions and random survival forests, to predict the event from the landmark time. We also show how predictive tools can be combined into a superlearner. The performances are evaluated by cross-validation using estimators of Brier Score and the area under the Receiver Operating Characteristic curve adapted to censored data. RESULTS: We demonstrate in a simulation study the benefits of machine learning survival methods over standard survival models, especially in the case of numerous and/or nonlinear relationships between the predictors and the event. We then applied the methodology in two prediction contexts: a clinical context with the prediction of death in primary biliary cholangitis, and a public health context with age-specific prediction of death in the general elderly population. CONCLUSIONS: Our methodology, implemented in R, enables the prediction of an event using the entire longitudinal patient history, even when the number of repeated markers is large. Although introduced with mixed models for the repeated markers and methods for a single right censored time-to-event, the technique can be used with any other appropriate modeling technique for the markers and can be easily extended to competing risks setting. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at (10.1186/s12874-022-01660-3). BioMed Central 2022-07-11 /pmc/articles/PMC9275051/ /pubmed/35818025 http://dx.doi.org/10.1186/s12874-022-01660-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Technical Advance
Devaux, Anthony
Genuer, Robin
Peres, Karine
Proust-Lima, Cécile
Individual dynamic prediction of clinical endpoint from large dimensional longitudinal biomarker history: a landmark approach
title Individual dynamic prediction of clinical endpoint from large dimensional longitudinal biomarker history: a landmark approach
title_full Individual dynamic prediction of clinical endpoint from large dimensional longitudinal biomarker history: a landmark approach
title_fullStr Individual dynamic prediction of clinical endpoint from large dimensional longitudinal biomarker history: a landmark approach
title_full_unstemmed Individual dynamic prediction of clinical endpoint from large dimensional longitudinal biomarker history: a landmark approach
title_short Individual dynamic prediction of clinical endpoint from large dimensional longitudinal biomarker history: a landmark approach
title_sort individual dynamic prediction of clinical endpoint from large dimensional longitudinal biomarker history: a landmark approach
topic Technical Advance
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275051/
https://www.ncbi.nlm.nih.gov/pubmed/35818025
http://dx.doi.org/10.1186/s12874-022-01660-3
work_keys_str_mv AT devauxanthony individualdynamicpredictionofclinicalendpointfromlargedimensionallongitudinalbiomarkerhistoryalandmarkapproach
AT genuerrobin individualdynamicpredictionofclinicalendpointfromlargedimensionallongitudinalbiomarkerhistoryalandmarkapproach
AT pereskarine individualdynamicpredictionofclinicalendpointfromlargedimensionallongitudinalbiomarkerhistoryalandmarkapproach
AT proustlimacecile individualdynamicpredictionofclinicalendpointfromlargedimensionallongitudinalbiomarkerhistoryalandmarkapproach